Literature DB >> 21554258

Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis.

Cecilia Sheen, Tiffaney Vincent, David Barrett, Edwin M Horwitz, Jessica Hulitt, Eliza Strong, Stephan A Grupp, David T Teachey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21554258      PMCID： PMC4119812          DOI： 10.1111/j.1365-2141.2011.08696.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL.

Authors:  David T Teachey; Dana A Obzut; Jonathan Cooperman; Junjie Fang; Martin Carroll; John K Choi; Peter J Houghton; Valerie I Brown; Stephan A Grupp
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

2.  Statins as immunomodulators: comparison with interferon-beta 1b in MS.

Authors:  O Neuhaus; S Strasser-Fuchs; F Fazekas; B C Kieseier; G Niederwieser; H P Hartung; J J Archelos
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

3.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Sue C Kaste; Deqing Pei; John C Panetta; Xiangjun Cai; Cheng Cheng; Geoffrey Neale; Scott C Howard; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

Review 4.  Osteonecrosis in children and adolescents with cancer - an adverse effect of systemic therapy.

Authors:  Alessandra Sala; Leonard A Mattano; Ronald D Barr
Journal:  Eur J Cancer       Date:  2006-12-13       Impact factor: 9.162

5.  Differences in antitumor effects of various statins on human pancreatic cancer.

Authors:  Helena Gbelcová; Martin Lenícek; Jaroslav Zelenka; Zdenek Knejzlík; Gabriela Dvoráková; Marie Zadinová; Pavla Poucková; Michal Kudla; Peter Balaz; Tomás Ruml; Libor Vítek
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

6.  Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.

Authors:  Jianghong Wu; W Wei-Lynn Wong; Fereshteh Khosravi; Mark D Minden; Linda Z Penn
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

7.  Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model.

Authors:  Kentaro Iwakiri; Yutaka Oda; Yasunori Kaneshiro; Hiroyoshi Iwaki; Toshiaki Masada; Akio Kobayashi; Akira Asada; Kunio Takaoka
Journal:  J Orthop Sci       Date:  2008-10-09       Impact factor: 1.601

8.  mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

Authors:  David T Teachey; Cecilia Sheen; Junior Hall; Theresa Ryan; Valerie I Brown; Jonathan Fish; Gregor S D Reid; Alix E Seif; Robin Norris; Yueh J Chang; Martin Carroll; Stephan A Grupp
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

9.  MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM.

Authors:  A A Rambal; Z L G Panaguiton; L Kramer; S Grant; H Harada
Journal:  Leukemia       Date:  2009-04-30       Impact factor: 11.528

10.  Statins induce lethal effects in acute myeloblastic leukemia [corrected] cells within 72 hours.

Authors:  Lillian P Burke; Cynthia A Kukoly
Journal:  Leuk Lymphoma       Date:  2008-02
  10 in total
  4 in total

1.  Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Debbie Piktel; Rajesh R Nair; Stephanie L Rellick; Werner J Geldenhuys; Karen H Martin; Michael D Craig; Laura F Gibson
Journal:  Cancers (Basel)       Date:  2022-05-28       Impact factor: 6.575

2.  The impact of high total cholesterol and high low-density lipoprotein on avascular necrosis of the femoral head in low-energy femoral neck fractures.

Authors:  Xianshang Zeng; Ke Zhan; Lili Zhang; Dan Zeng; Weiguang Yu; Xinchao Zhang; Mingdong Zhao; Zhicheng Lai; Runzhen Chen
Journal:  J Orthop Surg Res       Date:  2017-02-17       Impact factor: 2.359

3.  Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia.

Authors:  Austin B Henslee; Timothy A Steele
Journal:  Biomark Res       Date:  2018-08-09

4.  Bisphosphonate Combination Therapy in the Management of Postchemotherapy Avascular Necrosis of the Femoral Head in Adolescents and Young Adults: A Retrospective Study From India.

Authors:  Sanjay Agarwala; Shripad D Banavali; Mayank Vijayvargiya
Journal:  J Glob Oncol       Date:  2018-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.